FSEAX vs. FPHAX

Last updated Jun 25, 2026

FSEAX (Fidelity Emerging Asia Fund) and FPHAX (Fidelity Select Pharmaceuticals Portfolio) are both mutual funds - FSEAX is a Asia Pacific Equities fund managed by Fidelity, while FPHAX is a Health & Biotech Equities fund managed by Fidelity. Over the past 10 years, FSEAX returned 15.93%/yr vs 12.48%/yr for FPHAX. At a 0.41 correlation, their price movements are largely independent. FSEAX charges 1.02%/yr vs 0.75%/yr for FPHAX.

Performance

FSEAX vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Emerging Asia Fund (FSEAX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FSEAX achieves a 34.25% return, which is significantly higher than FPHAX's 10.33% return. Over the past 10 years, FSEAX has outperformed FPHAX with an annualized return of 15.93%, while FPHAX has yielded a comparatively lower 12.48% annualized return.

FSEAX

• 1D: -4.96%
• 1M: 3.85%
• YTD: 34.25%
• 6M: 35.63%
• 1Y: 58.33%
• 3Y*: 33.58%
• 5Y*: 7.23%
• 10Y*: 15.93%

FPHAX

• 1D: 1.16%
• 1M: 2.43%
• YTD: 10.33%
• 6M: 8.90%
• 1Y: 42.54%
• 3Y*: 18.15%
• 5Y*: 12.69%
• 10Y*: 12.48%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FSEAX vs. FPHAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FSEAX Fidelity Emerging Asia Fund	34.25%	36.43%	21.80%	13.58%	-31.26%	-14.91%	73.43%	30.97%	-15.08%	45.13%
FPHAX Fidelity Select Pharmaceuticals Portfolio	10.33%	30.41%	9.39%	12.54%	0.94%	11.79%	11.16%	31.73%	5.41%	10.70%

Correlation

The correlation between FSEAX and FPHAX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (5Y) Calculated over the trailing 5-year period	0.36
Correlation (10Y) Calculated over the trailing 10-year period	0.40
Correlation (All Time) Calculated using the full available price history since Jun 18, 2001	0.41

The correlation between FSEAX and FPHAX shifts across timeframes, from 0.26 (1 year) to 0.41 (all time), reflecting how their relationship changes across market environments.

Return for Risk

FSEAX vs. FPHAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSEAX

FSEAX Risk / Return Rank: 85
FSEAX Sharpe Ratio Rank: 90
FSEAX Sortino Ratio Rank: 72
FSEAX Omega Ratio Rank: 84
FSEAX Calmar Ratio Rank: 92
FSEAX Martin Ratio Rank: 89

FPHAX

FPHAX Risk / Return Rank: 69
FPHAX Sharpe Ratio Rank: 68
FPHAX Sortino Ratio Rank: 66
FPHAX Omega Ratio Rank: 55
FPHAX Calmar Ratio Rank: 89
FPHAX Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSEAX vs. FPHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Emerging Asia Fund (FSEAX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FSEAX	FPHAX	Difference
Sharpe ratio: Return per unit of total volatility	2.74	2.21	+0.53
Sortino ratio: Return per unit of downside risk	3.23	3.08	+0.15
Omega ratio: Gain probability vs. loss probability	1.51	1.37	+0.14
Calmar ratio: Return relative to maximum drawdown	4.69	4.30	+0.38
Martin ratio: Return relative to average drawdown	16.09	11.77	+4.33

FSEAX vs. FPHAX - Sharpe Ratio Comparison

The current FSEAX Sharpe Ratio is 2.74, which is comparable to the FPHAX Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of FSEAX and FPHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FSEAX vs. FPHAX - Drawdown Comparison

The maximum FSEAX drawdown since its inception was -65.59%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for FSEAX and FPHAX.

Drawdown Indicators

	FSEAX	FPHAX	Difference
Max Drawdown Largest peak-to-trough decline	-65.59%	-38.26%	-27.33%
Max Drawdown (1Y) Largest decline over 1 year	-13.42%	-10.33%	-3.09%
Max Drawdown (3Y) Largest decline over 3 years	-17.54%	-28.82%	+11.28%
Max Drawdown (5Y) Largest decline over 5 years	-53.64%	-28.82%	-24.82%
Max Drawdown (10Y) Largest decline over 10 years	-58.07%	-28.82%	-29.25%
Current Drawdown Current decline from peak	-4.96%	-2.00%	-2.96%
Average Drawdown Average peak-to-trough decline	-24.64%	-9.16%	-15.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.90%	3.77%	+0.13%

Volatility

FSEAX vs. FPHAX - Volatility Comparison

Fidelity Emerging Asia Fund (FSEAX) has a higher volatility of 13.77% compared to Fidelity Select Pharmaceuticals Portfolio (FPHAX) at 5.86%. This indicates that FSEAX's price experiences larger fluctuations and is considered to be riskier than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FSEAX	FPHAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.77%	5.86%	+7.91%
Volatility (6M) Calculated over the trailing 6-month period	20.57%	14.44%	+6.13%
Volatility (1Y) Calculated over the trailing 1-year period	23.00%	20.14%	+2.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.49%	18.11%	+5.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.32%	17.86%	+3.46%

FSEAX vs. FPHAX - Expense Ratio Comparison

FSEAX has a 1.02% expense ratio, which is higher than FPHAX's 0.75% expense ratio.

Dividends

FSEAX vs. FPHAX - Dividend Comparison

FSEAX's dividend yield for the trailing twelve months is around 0.16%, less than FPHAX's 5.04% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FPHAX Fidelity Select Pharmaceuticals Portfolio	5.04%	5.68%	1.90%	8.08%	5.18%	11.09%	8.85%	8.33%	1.65%	1.62%	1.07%	12.63%
FSEAX Fidelity Emerging Asia Fund	0.16%	0.22%	0.00%	0.08%	0.00%	14.14%	14.10%	6.15%	3.44%	0.05%	1.26%	0.44%

Frequently Asked Questions

Can I hold both FSEAX and FPHAX in my portfolio?

FSEAX and FPHAX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FSEAX or FPHAX?

FSEAX has higher volatility (13.77%) compared to FPHAX (5.86%). In terms of maximum drawdown, FSEAX dropped -65.59% vs FPHAX's -38.26%.

Which has better risk-adjusted returns?

FSEAX currently has the higher Sharpe Ratio (2.74 vs 2.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.